Navigation Links
Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
Date:10/15/2008

ed patients were end-stage and had no effective therapies available. JX-594 multiplies selectively within cancer cells, leading to their destruction. These newly created copies of JX-594 are then released and are able to infect and eradicate other tumor cells both locally and in distant sites in the body. This cycle of JX-594 replication, cancer cell destruction, release and spread is then repeated. Normal cells are not affected by JX-594 resulting in safety and tolerability. The poxvirus strain backbone of JX-594 has been used safely in millions of people as part of a worldwide vaccination program. This strain naturally targets cancer cells due to common genetic defects in cancer cells. JX-594 was engineered to enhance this natural safety and cancer-selectivity by deleting its thymidine kinase (TK) gene, thus making it dependent on the cellular TK expressed at persistently high levels in cancer cells. To enhance product efficacy, JX-594 is also engineered to express the GM-CSF protein. GM-CSF complements the cancer cell lysis work of the product candidate, leading to a cascade of events resulting in tumor necrosis, tumor vasculature shutdown and an anti-tumoral immune attack.

About Jennerex

Jennerex Biotherapeutics was established in San Francisco and in Ottawa in 2006 with Dr. David Kirn (CEO) in San Francisco and Dr. John Bell (CSO) from the Ottawa Health Research Institute/University of Ottawa. Jennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The company's lead product JX-594, currently in an international Phase 2 trial for primary liver cancer, demonstrated promising Phase 1 efficacy and safety results in patients with a diverse array of common large market cancers. Jennerex's products target, attack and eradicate cancers through a novel and potent oncolytic mechanism that is dependent on highly-specific replication of the
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
2. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
3. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
4. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
5. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
6. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
7. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
8. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
9. Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
10. Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
11. CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... received a patent acceptance notice from the Israeli patent ... to prevent or reduce tissue damage caused by an ... when cardiac vessels are opened after a blockage causing ... stroke victims. Damage can be caused to ...
(Date:3/26/2015)... March 26, 2015 InfuSystem Holdings, Inc. (NYSE MKT: ... services for the healthcare industry in the United ... today it has secured a new $45.0 million credit facility ... $36.5 million credit facility with its prior lender group.  ... the new five-year senior secured credit agreement comprised of a ...
(Date:3/26/2015)... 2015  Oxis Biotech, Inc. (OXIS), a ... [OTC: OXIS] and [Euronext Paris: OXI.PA] announced ... agreement with the University of Pittsburgh related ... Xiang-Qun Xie , Associate Dean for ... of Pharmacy.  These patents/intellectual properties relate to ...
Breaking Medicine Technology:RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 2Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 3
... 2010 Omnicell, Inc ., (Nasdaq: ... to acute healthcare facilities, will display its latest innovations ... (ASHP) Midyear Clinical Meeting and Exhibition from December ... previewed include the new Omnicell Savvy™ mobile medication system; ...
... is natural that all customers using the services of online ... for them and getting their order within the shortest possible ... and well-taken. This site assures new and regular clients with ... security. It uses the most updated methods to make every ...
Cached Medicine Technology:Omnicell to Showcase Latest Product Innovations at ASHP 2Omnicell to Showcase Latest Product Innovations at ASHP 3Omnicell to Showcase Latest Product Innovations at ASHP 4Omnicell to Showcase Latest Product Innovations at ASHP 5A New Online Pharmacy rxbuys.com by RX Corp Offers its Services to International Clients 2
(Date:3/26/2015)... 26, 2015 Doctors Scott Sullivan and ... Breast Surgery (CRBS) and the St. Charles ... to announce that board certified Surgical Oncologist Dr. William ... surgeons. Ordoyne joins fellow breast surgical oncologist Alan Stolier, ... Frank DellaCroce, M.D., FACS; Scott Sullivan, M.D., FACS; Chris ...
(Date:3/26/2015)... MALVERN, PA (PRWEB) March 26, 2015 ... leading providers of continuing medical education, the ... for Culinary Medicine at Tulane University are ... in Culinary Medicine. The interdisciplinary program ... Specialist (CCMS) credential, is designed for physicians, nurse ...
(Date:3/26/2015)... 2015 Visiting Nurse Association of ... annual gala fundraiser, Lighting the Way, Brightening the Day, ... The Madison Hotel in Morristown, NJ. , Guests ... renowned musician Rio Clemente, delightful cuisine, an extensive silent ... Hertzel. Additionally, two prestigious awards will be presented to ...
(Date:3/26/2015)... CA (PRWEB) March 26, 2015 Dr. ... are proud to announce expanded offerings for Bay Area ... Francisco Dental Implant Center has long been a top-rated ... expanded its offerings to meet the strong demand by ... our reputation as a top-rated dental implant facility in ...
(Date:3/26/2015)... Innovative research and additional funding ... often fatal ruptures, says The Bee Foundation, a ... of brain aneurysms and funding innovative research that ... attention with the death of longtime WABC-TV ... Friday after suffering a ruptured brain aneurysm. (Source: ...
Breaking Medicine News(10 mins):Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 3Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 2Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 3
... Desperate Housewives, Star Joins The Wellness Community as National Spokesperson for ... PHILADELPHIA, Sept. 14 /PRNewswire-USNewswire/ -- Ricardo Antonio ... found himself in a role he hoped never to play again ... in late 2008 left Chavira shocked and overwhelmed with old memories ...
... , , , , ... new survey released today, 90 percent of plan sponsors believe that ... such as diabetes and heart disease are at the root of ... the greatest impact on controlling these escalating costs, nearly 60 percent ...
... a major public health problem. Affecting almost 1% of ... social toll in addition to the distress, dysfunction, disability ... of the disease are present from birth, other aspects ... expressed in early adulthood with long-lasting implications for most ...
... , , ... "The Dr. Oz Show," a high octane, multi-topic hour-long series ... Dr. Mehmet Oz, premieres in syndication today (check local listings). ... recently announced "Core Team Oz" guest contributors, fashion and style expert ...
... NEW YORK, Sept. 14 To educate healthcare professionals ... and care, Minority Health Care Communications (MHCC) will hold the National ... York Academy of Medicine in New York. , , ... New York, and the location is significant, says conference Director K. ...
... ... partners with AiRISTA to provide Wi-Fi-based RFID solutions. , ... Sparks, Maryland (PRWEB) September 14, ... Corporation (DCC) to promote, distribute, implement and support AiRISTA,s solutions and technologies ( ...
Cached Medicine News:Health News:Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 2Health News:Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 3Health News:Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 4Health News:Economic Conditions Signal Long-Term Shift in Rx Benefit Approach 2Health News:Economic Conditions Signal Long-Term Shift in Rx Benefit Approach 3Health News:Economic Conditions Signal Long-Term Shift in Rx Benefit Approach 4Health News:The future of schizophrenia 2Health News:The future of schizophrenia 3Health News:The future of schizophrenia 4Health News:The future of schizophrenia 5Health News:'The Dr. Oz Show' Premieres Today Nationwide 2Health News:'The Dr. Oz Show' Premieres Today Nationwide 3Health News:'The Dr. Oz Show' Premieres Today Nationwide 4Health News:'The Dr. Oz Show' Premieres Today Nationwide 5Health News:Latino HIV/AIDS Crisis Demands Attention - Health Care Professionals from Across the United States Gather in New York City for National Conference on Latinos and AIDS to Address Concerns 2Health News:Latino HIV/AIDS Crisis Demands Attention - Health Care Professionals from Across the United States Gather in New York City for National Conference on Latinos and AIDS to Address Concerns 3Health News:AiRISTA's Unified Visibility Solutions Bringing Together Wi-Fi RTLS, And Telemetry Offer Enormous Business Opportunities To Systems Integrators 2
... System consists of a sterile Hemostatic ... Compression System.,Both devices work together to ... achieves topical hemostasis by facilitating clotting ... Femoral Compression System provides external compression ...
... WaveScan WaveFront System is an ophthalmic diagnostic ... wavefront aberrations of the human eye using ... be used to determine regular (sphero-cylindrical) refractive ... or blurry vision in the human eye. ...
... LADARWave® device gives you ... measure and display the ... individual eye. This capability ... a better understanding of ...
... eye drops quickly remove redness ... other pollutants and provide protection ... and the sun. This unique ... LIQUIFILM®, to soothe, cool and ...
Medicine Products: